INS and diabetes mellitus: These preliminary findings provide concept-level evidence that B. longum CKD1 may represent a safe and effective therapeutic option, either as a noninvasive monotherapy or as an adjunct to conventional insulin therapy, for managing diabetes mellitus in companion animals.